成人VR视频

Event

Biostatistics Seminar

Tuesday, October 13, 2015 15:30to16:30
Purvis Hall Room 24, 1020 avenue des Pins Ouest, Montreal, QC, H3A 1A2, CA

James Hanley, PhD

Professor, Department of Epidemiology, Biostatistics and Occupational Health, 成人VR视频

Population data to measure mortality reductions produced by organized cancer screening: analyze with care

ALL ARE WELCOME

Abstract:

Although many of the trials were carried out decades ago, and did not necessarily produce valid or precise estimates of the reductions that might be expected from a sustained screening program, data from randomized cancer screening trials are still relied on by many task forces. Re-analyses of the published data from two trials will be used to illustrate why, if screening does what it is intended to do, hazard rates are automatically non-proportional; they cannot be handled within prevailing Cochrane meta-analysis practices.

Increasingly, the focus is on non-experimental evidence, i.e., data from populations where organized screening programs have been introduced.

In the evaluation of the impact of such programs, before-after comparisons of cancer mortality rates need to take account of concomitant improvements in cancer care over these same decades. Time-, age- and place-matched comparisons, and attention to which deaths could/could not be averted by the screening program, are essential for valid estimates of benefit.

Using organized population-based programs of mammography screening for breast cancer as an example, we show that by ignoring these issues, many of the prevailing statistical approaches to the analysis of such population-based data underestimate the mortality reductions produced by these programs. Statistical approaches that can deal with these 'dilutions' will be described.

[Joint work with Ailish Hannigan, Olli Saarela and Harald Weedon-Fekjaer; supported by CIHR]

Bio:

Back to top